Skye Medicine Closes Seed Round Exceeding RMB 120 Million to Advance Next-Generation CAR-T Therapies
Skye Medicine (Shanghai) Co., Ltd. closed a seed financing round of over RMB 120 million at the beginning of this year, co-led by Hony Capital and Med Fine Capital, with participation from Suzhou Venture Capital, CS Capital, Yingxian Investment, and Addor Capital.
Company News | 2026-06
More